In conclusion, our results provide a deeper understanding of the role of anti-HER2 binding kinetics and affinity of HCT-mono-mIL12 in tumor targeting and intratumoral diffusive penetration, thereby determining the tumor infiltration and in situ proliferation and activation of tumor-infiltrating effector T cells, and consequently the antitumor activity. This evidence concerns the gene ERBB2 and neoplasm.